Articles

Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis

Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria-CSIC, Santander, Spain;Josep Carreras Leukemia Research Institute-Campus Clinic, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Josep Carreras Leukemia Research Institute-Campus Clinic, Department of Biomedicine, School of Medicine, University of Barcelona, Spain
Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, UK
Department of Paediatrics, University of Oxford, UK
Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands
Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano Bicocca, Fondazione MBBM, Monza, Italy
Pediatric Hematology, A. Trousseau Hospital, Paris, France
Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano Bicocca, Fondazione MBBM, Monza, Italy
Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria-CSIC, Santander, Spain
Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria-CSIC, Santander, Spain
CNAG-CRG, Center for Genomic Regulation, Barcelona, Spain;Universitat Pompeu Fabra, Barcelona, Spain
Interfant Trial Data Center, University of Milano-Bicocca, Monza, Italy
Department of Paediatrics, University of Oxford, UK;MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, UK
Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands
Interfant Trial Data Center, University of Milano-Bicocca, Monza, Italy
Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria-CSIC, Santander, Spain
Josep Carreras Leukemia Research Institute-Campus Clinic, Department of Biomedicine, School of Medicine, University of Barcelona, Spain;Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Barcelona, Spain
Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands
Vol. 104 No. 6 (2019): June, 2019 https://doi.org/10.3324/haematol.2018.206375